Hereditary gynecologic cancers: Differential diagnosis, surveillance, management and surgical prophylaxis

Familial Cancer

Volumn 7, Issue 1, 2008, Pages 53-58

  Lu, Karen H ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

BRCA1; Endometrial cancer; Lynch syndrome; Ovarian cancer

Indexed keywords

ADULT; BREAST CANCER; BREAST OVARIAN CANCER SYNDROME; CANCER PREVENTION; CANCER SUSCEPTIBILITY; CASE REPORT; CLINICAL FEATURE; COLON CANCER; COLORECTAL CANCER; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; ENDOMETRIUM CANCER; FAMILIAL CANCER; FEMALE; GYNECOLOGIC CANCER; HUMAN; HUMAN TISSUE; OVARY CANCER; PATIENT COUNSELING; PERITONEUM CANCER; PRIORITY JOURNAL; SYMPTOM; TUMOR SUPPRESSOR GENE; UTERUS CANCER; BREAST TUMOR; COLORECTAL TUMOR; ENDOMETRIUM TUMOR; GENETIC COUNSELING; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; HYSTERECTOMY; MIDDLE AGED; OVARIECTOMY; OVARY TUMOR; REVIEW; RISK FACTOR;

ORAL CONTRACEPTIVE AGENT;

ADULT; BREAST NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; CONTRACEPTIVES, ORAL; DIAGNOSIS, DIFFERENTIAL; ENDOMETRIAL NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; HYSTERECTOMY; MIDDLE AGED; OVARIAN NEOPLASMS; OVARIECTOMY; RISK FACTORS;

EID: 46449117480     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-007-9144-x     Document Type: Conference Paper

References (35)

1. A Jemal 2006 Cancer statistics, 2006 CA Cancer J Clin 56 2 106 130
2. M Aarnio 1999 Cancer risk in mutation carriers of DNA-mismatch-repair genes Int J Cancer 81 2 214 218
3. MG Dunlop 1997 Cancer risk associated with germline DNA mismatch repair gene mutations Hum Mol Genet 6 1 105 110
4. K Lu 2004 Gynecological malignancy as a "Sentinel Cancer" for women with HNPCC Gynecol Oncol 92 421
5. A Umar 2004 Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability J Natl Cancer Inst 96 4 261 268
6. MJ Berends 2003 Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis J Clin Oncol 21 23 4364 4370
7. Lu K, S.J., Rodabaugh K, Sun C, Daniels MS, White KG, Soliman PT, Luthra R, Broaddus RR. Defining criteria for Lynch Syndrome/HNPCC in women under 50 with endometrial cancer: Final results of a prospective, multi-center study. in 1st Conference of InSIGHT, the International Society for Gastrointestinal Hereditary Tumors. 2005. Newcastle, UK: Familial Cancer
8. AL Millar 1999 Mismatch repair gene defects contribute to the genetic basis of double primary cancers of the colorectum and endometrium Hum Mol Genet 8 5 823 829
9. PT Soliman 2004 Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases Gynecol Oncol 94 2 456 462
10. W Burke 1997 Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium JAMA 277 12 997 1003
11. NCCN Clinical Practice Guidelines in Oncology: Genetic/Familial High-Risk Assessment: Breast and Ovarian. Vol. Version 1.2006. 2006, Rockledge, PA: National Comprehensive Cancer Network
12. Lu KH, Soliman PT, Boyd-Rogers SG, Daniels MS, Broaddus RR, Lynch PM, Peterson SK (2005) A prospective pilot study of combined colon and endometrial cancer screening in women with HNPCC. Familial Cancer 4:104-105
13. Combination oral contraceptive use and the risk of endometrial cancer 1987 The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development JAMA 257 6 796 800
14. KM Schmeler 2006 Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome N Engl J Med 354 3 261 269
15. L Chung 2003 Unexpected endometrial cancer at prophylactic hysterectomy in a woman with hereditary nonpolyposis colon cancer Obstet Gynecol 102 5 Pt 2 1152 1155
16. TS Frank 1998 Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk J Clin Oncol 16 7 2417 2425
17. KH Lu 1999 A population-based study of BRCA1 and BRCA2 mutations in Jewish women with epithelial ovarian cancer Obstet Gynecol 93 1 34 37
18. R Moslehi 2000 BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer Am J Hum Genet 66 4 1259 1272
19. KA Metcalfe 2005 The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers Gynecol Oncol 96 1 222 226
20. DA Levine 2003 Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations J Clin Oncol 21 22 4222 4227
21. KN Gaarenstroom 2006 Efficacy of screening women at high risk of hereditary ovarian cancer: results of an 11-year cohort study Int J Gynecol Cancer 16 Suppl 1 54 59
22. PA Meeuwissen 2005 Outcome of surveillance and prophylactic salpingo-oophorectomy in asymptomatic women at high risk for ovarian cancer Gynecol Oncol 97 2 476 482
23. D Stirling 2005 Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international Federation of gynecology and obstetrics system J Clin Oncol 23 24 5588 5596
24. The reduction in risk of ovarian cancer associated with oral-contraceptive use 1987 The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development N Engl J Med 316 11 650 655
25. SA Narod P Sun HA Risch 2001 Ovarian cancer, oral contraceptives, and BRCA mutations N Engl J Med 345 23 1706 1707
26. AS Whittemore 2004 Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations Br J Cancer 91 11 1911 1915
27. B Modan 2001 Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation N Engl J Med 345 4 235 240
28. SA Narod 2002 Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers J Natl Cancer Inst 94 23 1773 1779
29. TR Rebbeck 2002 Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations N Engl J Med 346 21 1616 1622
30. ND Kauff 2002 Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation N Engl J Med 346 21 1609 15
31. KM Schmeler 2006 Prophylactic Bilateral Salpingo-Oophorectomy Compared With Surveillance in Women With BRCA Mutations Obstet Gynecol 108 3 515 520
32. TR Rebbeck 2005 Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group J Clin Oncol 23 31 7804 7810
33. KH Lu 2000 Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy J Clin Oncol 18 14 2728 2732
34. TJ Colgan 2001 Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status Am J Surg Pathol 25 10 1283 1289
35. CB Powell 2005 Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy J Clin Oncol 23 1 127 132